Bronchoscopy
1
Pipeline Programs
4
Companies
3
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
1
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
EisaiAQUAVAN®
AmbuClinical Validation Trial of a Single-use Bronchoscope (Ambu® aScope ™ 4)
AmbuaScope 4 Broncho
Clinical Trials (3)
Total enrollment: 250 patients across 3 trials
An Effectiveness and Safety Study of AQUAVAN® Injection (Fospropofol Disodium) for Sedation During Flexible Bronchoscopy
Start: Apr 2006Est. completion: May 2007250 patients
Phase 3Completed
Clinical Validation Trial of a Single-use Bronchoscope (Ambu® aScope ™ 4)
Start: Mar 2018Est. completion: Aug 2018
N/ACompleted
Prospective Non-interventional Evaluation of Intubation and Intensive Care Use of the New aScope™ 4 Broncho and aView
Start: Sep 2017Est. completion: Jan 2018
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 late-stage (Phase 3) programs — potential near-term approvals
4 companies competing in this space